
‘Groundbreaking’ Gene-Editing Therapy Receives Ethical Thumbs Up
Casgevy is a new treatment for sickle cell disease, a blood disorder that affects approximately 100,000 Americans.
Casgevy is a new treatment for sickle cell disease, a blood disorder that affects approximately 100,000 Americans.
Their discovery sparked research into new treatments for cancer and other diseases, earning the two female scientists the 2020 Nobel Prize in Chemistry, but it also poses a host of bioethical questions.
A new experiment at Cornell University hopes to fix genetic mutations that cause diseases to be inherited from a father to his children, and to examine and fix causes of male infertility.
Subscriber Service CenterAlready a subscriber? Renew or manage your subscription here.
Subscribe for just $49.95 $32.50!Start your Register subscription today.
Give a Gift SubscriptionBless friends, family or clergy with a gift of the Register.
Order NowOrder Bulk SubscriptionsGet a discount on 6 or more copies sent to your parish, organization or school.
Order NowSign-up for E-NewsletterGet Register Updates sent daily or weeklyto your inbox.
Sign Up